Selected article for: "consecutive test and negative consecutive test"

Author: Xiong, Yong; Song, Shihui; Ye, Guangming; Wang, Xinghuan
Title: Family cluster of three recovered cases of pneumonia due to severe acute respiratory syndrome coronavirus 2 infection
  • Cord-id: bxvgr6qg
  • Document date: 2020_5_4
  • ID: bxvgr6qg
    Snippet: The coronavirus disease (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in late 2019 and has affected more than 1 270 000 people worldwide. The numbers of reported cases continue to rise and threaten global health. Transmissions among family members are frequently observed, although the route of transmission is partially known. Here we report three cases of SARS-CoV-2 infection within one family. Sequencing of the S g
    Document: The coronavirus disease (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in late 2019 and has affected more than 1 270 000 people worldwide. The numbers of reported cases continue to rise and threaten global health. Transmissions among family members are frequently observed, although the route of transmission is partially known. Here we report three cases of SARS-CoV-2 infection within one family. Sequencing of the S gene of the viral genome showed 100% identity among samples, suggesting that the same strain caused the infection. Following treatment with oseltamivir and short-term methylprednisolone combined with symptomatic management, all three patients recovered within 3 weeks, as evidenced by the disappearance of their symptoms, clearance of pulmonary infiltrates and consecutive negative molecular diagnostic test findings. Our observations suggest the importance of preventing family transmission and the efficacy of current integrated treatment for mild/moderate pneumonia in COVID-19 cases.

    Search related documents:
    Co phrase search for related documents
    • admission day and low near normal: 1
    • admission day and lung auscultation: 1, 2, 3
    • admission day and lung inflammation: 1, 2
    • admission day and lung opacity: 1, 2, 3
    • admission day and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
    • admission prior and lopinavir ritonavir: 1, 2, 3, 4
    • admission prior and lung inflammation: 1, 2, 3, 4
    • admission prior and lung opacity: 1
    • admission prior and lymphocyte count: 1, 2
    • lopinavir ritonavir and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8
    • lopinavir ritonavir and lung opacity: 1, 2
    • lopinavir ritonavir and lung outer zone: 1
    • lopinavir ritonavir and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • lung auscultation and lymphocyte count: 1
    • lung inflammation and lymphocyte count: 1, 2, 3, 4, 5, 6, 7
    • lung opacity and lymphocyte count: 1, 2, 3, 4, 5, 6, 7